In some cases, neurological symptoms may temporarily worsen before improvement is observed
near research site (if localized SubQ modeling possible) or systemic administration for broader studies Cycle length: 46 weeks on for acute injury models (extend to 8 weeks if needed for chronic issues), followed by 24 weeks off to reset sensitivity Use strictly according to the manufacturers directions
However, as insulin sensitivity eventually declines and insulin demand rises, -cells can no longer sustain insulin production, and the patient enters the dysfunctional (decompensated) stage, where hypoinsulinemia, hyperglycemia, and dyslipidemia appear (Hu et al., 2022)
Antioxidant biomarkers like catalase, superoxide dismutase, and malondialdehyde indicate oxidative balance